Semtech (NASDAQ:SMTC) had its numbers increased by Lazard Capital (NYSE:LAZ) as the company should benefit from the design will pipeline. A buy rating was issued with a price target of $39.
Shares are higher by about 2.3 percent.
Bristol-Myers Squibb (NYSE:BMY) had its price target increased by Jefferies (JEF), as the company is expected to enter a period of sustained growth starting in 2013. A $41 pirce target was issued.
Shares are lower by about nine tenths of a percent.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.